Skip to main content
Terug
Watch Compare

BioAtla, Inc.

Datakwaliteit: 83%
BCAB
NASDAQ Manufacturing Chemicals
€ 4,46
▼ € 0,06 (-1,33%)
Marktkapitalisatie: 7,46 M
Prijs
€ 4,50
Marktkapitalisatie
7,46 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -48,20 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-1108,50%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,54
Interest CoverageN/A

Waardering

PE (TTM)
-0,13
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -0,1 -1,5
P/B — 1,6
ROE % — -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2026 — 0,0 —

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q32025 -€ 14,83 -€ 13,50 +9,0%
Q22025 -€ 14,67 -€ 16,00 -9,1%
Q12025 -€ 14,67 -€ 13,00 +11,4%
Q42024 -€ 19,00 -€ 15,00 +21,1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -59,61 M
ROE N/A ROA -277,00%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -48,20 M
ROIC -1108,50% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,54
Interest Coverage N/A Asset Turnover N/A
Working Capital -8,31 M Tangible Book Value -31,24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,13 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -646,50%
Market Cap 7,46 M Enterprise Value -863.829,0
Per Share
EPS (Diluted TTM) -1,01 Revenue / Share N/A
FCF / Share -29,09 OCF / Share -29,09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 80,87%
SBC-Adj. FCF -54,71 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 300.000,0 300.000,0
Net Income -59,61 M -69,78 M -123,46 M -106,48 M -95,40 M
EPS (Diluted) -1,01 -1,44 -2,58 -2,74 —
Gross Profit — — — — —
Operating Income -59,31 M -73,94 M -129,69 M -108,14 M -96,44 M
EBITDA — — — — —
R&D Expenses 43,57 M 63,10 M 103,73 M 79,35 M 58,27 M
SG&A Expenses — — — — —
D&A 373.000,0 925.000,0 1,22 M 1,20 M 1,33 M
Interest Expense — — — 0,0 3.000,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13,83 M 52,42 M 119,66 M 225,74 M 254,42 M
Total Liabilities 50,02 M 38,16 M 48,99 M 45,40 M 43,60 M
Shareholders' Equity -36,19 M 14,27 M 70,67 M 180,34 M 210,82 M
Total Debt — — — — —
Cash & Equivalents 7,12 M 49,05 M 111,47 M 215,51 M 244,98 M
Current Assets 8,01 M 51,23 M 116,41 M 220,43 M 247,29 M
Current Liabilities 21,92 M 14,54 M 28,34 M 23,13 M 19,81 M